A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia
Clinical trial NCT01626885 · COMPLETED
Trial details
- NCT number
- NCT01626885
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.